← Back to Clinical Trials
Recruiting NCT07715812

NCT07715812 E-diary vs Paper Diary in Binge Eating Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07715812
Status Recruiting
Phase
Sponsor Lindner Center of HOPE
Condition Binge Eating Disorder
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-07-30
Primary Completion 2027-12-30

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
The subject will complete e-diary for 2 weekscomplete paper diary for 2 weeks

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2026-07-30 with a primary completion date of 2027-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to examine how binge eating episodes are recorded using two different diary formats: a paper diary and an electronic diary and to see whether both formats collect information in the same way and to understand which of the two formats is easier to use

Eligibility Criteria

Inclusion Criteria: 1. Diagnosis of Binge Eating Disorder based on The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (5) criteria (as assessed with BED module of the structural clinical interview \[SCID\] (6) for DSM-5) 2. Reported frequency of minimum of 2 binge episodes/week 3. Age: over 18 years of age 4. Ability to understand and complete self-reporting measures 5 . The subject owns a smartphone compatible with Google Play or Apple App Store and is able to download and use apps appropriately. Exclusion Criteria: 1. Comorbid psychiatric conditions requiring immediate hospitalization (as assessed with MSE) 2. IInability to use smartphone or paper diary due to physical limitations or technical barriers (e.g., severe visual impairment) 3. Inability to read/write in English

Contact & Investigator

Central Contact

Anna I Guerdjikova, PhD,LISW, PhD,LISW

✉ anna.guerdjikova@lindnercenter.org

📞 5135360700

Frequently Asked Questions

Who can join the NCT07715812 clinical trial?

This trial is open to participants of all sexes, up to 18 Years, studying Binge Eating Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07715812 currently recruiting?

Yes, NCT07715812 is actively recruiting participants. Contact the research team at anna.guerdjikova@lindnercenter.org for enrollment information.

Where is the NCT07715812 trial being conducted?

This trial is being conducted at Mason, United States.

Who is sponsoring the NCT07715812 clinical trial?

NCT07715812 is sponsored by Lindner Center of HOPE. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology